IS1533B - Aðferð til framleiðslu á kristölluðu natrium salti, sem misst hefur allt vatn og sem saman stendur af 5-Chloro-3-(2-Thenoyl)-2-Oxindole-1-Carboxamide - Google Patents

Aðferð til framleiðslu á kristölluðu natrium salti, sem misst hefur allt vatn og sem saman stendur af 5-Chloro-3-(2-Thenoyl)-2-Oxindole-1-Carboxamide

Info

Publication number
IS1533B
IS1533B IS3309A IS3309A IS1533B IS 1533 B IS1533 B IS 1533B IS 3309 A IS3309 A IS 3309A IS 3309 A IS3309 A IS 3309A IS 1533 B IS1533 B IS 1533B
Authority
IS
Iceland
Prior art keywords
lossed
thenoyl
oxindole
carboxamide
chloro
Prior art date
Application number
IS3309A
Other languages
English (en)
Icelandic (is)
Other versions
IS3309A7 (is
Inventor
John Meldrum Allen Douglas
Thomas O'neill Brian
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS3309A7 publication Critical patent/IS3309A7/is
Publication of IS1533B publication Critical patent/IS1533B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS3309A 1987-02-02 1988-02-02 Aðferð til framleiðslu á kristölluðu natrium salti, sem misst hefur allt vatn og sem saman stendur af 5-Chloro-3-(2-Thenoyl)-2-Oxindole-1-Carboxamide IS1533B (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (2)

Publication Number Publication Date
IS3309A7 IS3309A7 (is) 1988-08-03
IS1533B true IS1533B (is) 1994-01-28

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3309A IS1533B (is) 1987-02-02 1988-02-02 Aðferð til framleiðslu á kristölluðu natrium salti, sem misst hefur allt vatn og sem saman stendur af 5-Chloro-3-(2-Thenoyl)-2-Oxindole-1-Carboxamide

Country Status (42)

Country Link
US (1) US5036099A (OSRAM)
EP (1) EP0277738B1 (OSRAM)
JP (1) JPS63201184A (OSRAM)
KR (1) KR900001422B1 (OSRAM)
CN (1) CN1022324C (OSRAM)
AP (1) AP52A (OSRAM)
AR (1) AR243182A1 (OSRAM)
AT (1) ATE73800T1 (OSRAM)
AU (1) AU587736B2 (OSRAM)
BG (1) BG51042A3 (OSRAM)
CA (1) CA1335590C (OSRAM)
CS (2) CS265250B2 (OSRAM)
CY (1) CY1775A (OSRAM)
DD (1) DD267490A5 (OSRAM)
DE (1) DE3869149D1 (OSRAM)
DK (1) DK44888A (OSRAM)
EC (1) ECSP941082A (OSRAM)
ES (1) ES2032955T3 (OSRAM)
FI (1) FI89598C (OSRAM)
GR (1) GR3004200T3 (OSRAM)
HK (1) HK132695A (OSRAM)
IE (1) IE60000B1 (OSRAM)
IL (1) IL85277A (OSRAM)
IN (1) IN171799B (OSRAM)
IS (1) IS1533B (OSRAM)
LV (1) LV10252B (OSRAM)
MA (1) MA21171A1 (OSRAM)
MY (1) MY102737A (OSRAM)
NO (1) NO170581C (OSRAM)
NZ (1) NZ223373A (OSRAM)
OA (1) OA08710A (OSRAM)
PH (1) PH26545A (OSRAM)
PL (1) PL149550B1 (OSRAM)
PT (1) PT86675B (OSRAM)
RO (1) RO105052B1 (OSRAM)
RU (1) RU2011381C1 (OSRAM)
SG (1) SG27994G (OSRAM)
SI (1) SI8810183A8 (OSRAM)
UA (1) UA25898A1 (OSRAM)
WO (1) WO1988005656A1 (OSRAM)
YU (1) YU46766B (OSRAM)
ZA (1) ZA88679B (OSRAM)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
ES2075055T3 (es) * 1988-10-18 1995-10-01 Pfizer Profarmacos de 3-acil-2-oxindol-1-carboxamidas antiinflamatorias.
MX18021A (es) * 1988-10-18 1993-11-01 Pfizer Pro-farmacos de la 3-acil-2-oxindol-1-carboxamidasanti-inflamatorias
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
US5270331A (en) * 1993-01-26 1993-12-14 Pfizer, Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) * 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) * 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
IL274383B2 (en) 2017-11-02 2024-03-01 Accurate Medical Therapeutics Ltd Catheter for embolization with integral filter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
ATE41420T1 (de) * 1984-02-07 1989-04-15 Pfizer 1,3-disubstituierte 2-oxindole und deren anwendung als analgetische und antiinflammatorische mittel.
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
IE57741B1 (en) * 1984-03-19 1993-03-24 Pfizer Process for making 2-oxindole-1-carboxamides and intermediates therefor
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
RO105052B1 (en) 1994-12-01
CS265250B2 (en) 1989-10-13
JPH0576945B2 (OSRAM) 1993-10-25
FI89598C (fi) 1993-10-25
IL85277A (en) 1994-02-27
NO884329L (no) 1988-09-29
US5036099A (en) 1991-07-30
AP52A (en) 1989-09-16
MA21171A1 (fr) 1988-10-01
YU46766B (sh) 1994-05-10
ZA88679B (en) 1989-09-27
EP0277738B1 (en) 1992-03-18
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
NO170581B (no) 1992-07-27
IE880269L (en) 1988-08-02
NZ223373A (en) 1989-06-28
WO1988005656A1 (en) 1988-08-11
CS354191A3 (en) 1992-04-15
IL85277A0 (en) 1988-07-31
DE3869149D1 (de) 1992-04-23
IE60000B1 (en) 1994-05-18
LV10252A (lv) 1994-10-20
IN171799B (OSRAM) 1993-01-09
MY102737A (en) 1992-09-30
EP0277738A1 (en) 1988-08-10
KR900001422B1 (ko) 1990-03-09
CS64888A2 (en) 1988-08-16
GR3004200T3 (OSRAM) 1993-03-31
PH26545A (en) 1992-08-19
AP8800081A0 (en) 1987-11-01
NO884329D0 (no) 1988-09-29
ATE73800T1 (de) 1992-04-15
PL149550B1 (en) 1990-02-28
AU587736B2 (en) 1989-08-24
OA08710A (fr) 1989-03-31
PL270415A1 (en) 1988-12-08
CN88100555A (zh) 1988-08-17
ES2032955T3 (es) 1996-07-16
ECSP941082A (es) 1994-12-15
AR243182A1 (es) 1993-07-30
CN1022324C (zh) 1993-10-06
DD267490A5 (de) 1989-05-03
FI89598B (fi) 1993-07-15
SG27994G (en) 1994-10-14
DK44888D0 (da) 1988-01-29
CY1775A (en) 1996-04-05
PT86675A (pt) 1988-03-01
NO170581C (no) 1992-11-04
KR880009961A (ko) 1988-10-06
PT86675B (pt) 1992-07-31
CA1335590C (en) 1995-05-16
RU2011381C1 (ru) 1994-04-30
IS3309A7 (is) 1988-08-03
UA25898A1 (uk) 1999-02-26
SI8810183A8 (sl) 1996-08-31
BG51042A3 (bg) 1993-01-15
AU1116088A (en) 1988-08-04
HK132695A (en) 1995-09-01
YU18388A (en) 1989-10-31
FI893647A0 (fi) 1989-08-01
DK44888A (da) 1988-08-03

Similar Documents

Publication Publication Date Title
IS3309A7 (is) Aðferð til framleiðslu á kristölluðu natrium salti, sem misst hefur allt vatn og sem saman stendur af 5-Chloro-3-(2-Thenoyl)-2-Oxindole-1-Carboxamide
NO881482D0 (no) Fremgangsmaate for fremstilling av substituerte di-t-butylfenoler.
FI90942B (fi) Kiinteän, kiteisen nedokromiilinatriumin valmistusmenetelmä
DK397387A (da) Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
FI843378A0 (fi) Tvaergradienta faeltlindningar foer avbildning med kaernmagnetisk resonans.
NO880187L (no) Superledende forbindelser av den k2if4strukturelle typen med hoeyovergangstemperatur, og fremgangsmaate for deresfremstilling.
DK51784A (da) Fremgangsmaade til fremstilling af hoejkrystallinsk natriumcefoperazon
NO162023C (no) Fremgangsmaate til fremstilling av antracyklinderivater.
FI840970A7 (fi) Indolijohdannaisia.
NO885435L (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
DK516087A (da) Fremgangsmaade til flokkulering af en vandig oploesning
DK68784D0 (da) Kontinuert fremgangsmade til fremstilling af 5-oxo-2,4-dichlor-4-substituerede pentannitriler
DK423284D0 (da) Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser
NO882030D0 (no) Fremgangsmaate til fremstilling av hydrasinderivater til bruk som antihypertensivt middel.
DK162645C (da) Analogifremgangsmaade til fremstilling af 5-(2-imidazolylethoxy)-thiophen-2-carboxylsyrederivater
DK367388D0 (da) Til fremstilling af hoejredrejende 3-(3-pyridyl)-1h,3h-pyrrolo(1,2-c)thiazol-7-carboxylsyre
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
NO880992D0 (no) Fremgangsmaate for fremstilling av pyridinderivater.
FI842972A7 (fi) Menetelmä 2,3-dihydrobentsopyranonijohdannaisten valmistamiseksi.
FI882887L (fi) Foer klaeder avsedd tvaett- och/eller torkmaskin, vars trumma staengs med regel.
FI881128L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbart nikotinsyra-litiumsaltsemihydrat.
NO883610D0 (no) Fremgangsmaate til fremstilling av substituerte tienoimidazol-derivater.
FI844067A7 (fi) Menetelmä 9-karbamoyylifluoreeni-johdannaisten valmistamiseksi.
NO880942D0 (no) Apparat for telemetrimaalinger i borehull.
NO910054D0 (no) Fremgangsmaate for fremstilling av 2,6-substituert-3,5-pyridindicarboxylsyrederivater.